prednisone has been researched along with Sleep Apnea Syndromes in 3 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarcoidosis is a chronic systemic granulomatous disease that occasionally affects the larynx." | 5.31 | Laryngeal sarcoidosis: treatment with the antileprosy drug clofazimine. ( Fradis, M; Golz, A; Löhle, E; Ridder, GJ; Strohhäcker, H, 2000) |
| "To determine if pediatric obstructive sleep apnea syndrome (OSAS) caused by adenotonsillar hypertrophy (ATH) could be treated by a short course of systemic corticosteroids, we conducted an open-label pilot study in which standardized assessments of symptomatology, OSAS severity, and adenotonsillar size were performed before and after a 5-day course of oral prednisone, 1." | 2.68 | Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy? ( Al-Ghamdi, SA; Brouillette, RT; Ducharme, FM; Manoukian, JJ; Morielli, A; Oudjhane, K, 1997) |
| "Sarcoidosis is a chronic systemic granulomatous disease that occasionally affects the larynx." | 1.31 | Laryngeal sarcoidosis: treatment with the antileprosy drug clofazimine. ( Fradis, M; Golz, A; Löhle, E; Ridder, GJ; Strohhäcker, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JK | 1 |
| Woodson, BT | 1 |
| Al-Ghamdi, SA | 1 |
| Manoukian, JJ | 1 |
| Morielli, A | 1 |
| Oudjhane, K | 1 |
| Ducharme, FM | 1 |
| Brouillette, RT | 1 |
| Ridder, GJ | 1 |
| Strohhäcker, H | 1 |
| Löhle, E | 1 |
| Golz, A | 1 |
| Fradis, M | 1 |
1 trial available for prednisone and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy?
Topics: Adenoidectomy; Adenoids; Administration, Oral; Child, Preschool; Female; Glucocorticoids; Humans; Hy | 1997 |
2 other studies available for prednisone and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Effects of prednisone and ibuprofen on radio frequency volume tissue reduction in a rabbit model.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Data Interpretation, Sta | 2002 |
Laryngeal sarcoidosis: treatment with the antileprosy drug clofazimine.
Topics: Adult; Airway Obstruction; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy | 2000 |